| Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology A Zimprich, S Biskup, P Leitner, P Lichtner, M Farrer, S Lincoln, ... Neuron 44 (4), 601-607, 2004 | 3409 | 2004 |
| Gastrointestinal dysfunction in Parkinson's disease A Fasano, NP Visanji, LWC Liu, AE Lang, RF Pfeiffer The Lancet Neurology 14 (6), 625-639, 2015 | 830 | 2015 |
| Non-motor symptoms in Parkinson's disease RF Pfeiffer Parkinsonism & related disorders 22, S119-S122, 2016 | 680 | 2016 |
| Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. RG Holloway, I Shoulson, S Fahn, K Kieburtz, A Lang, K Marek, ... Archives of neurology 61 (7), 1044-1053, 2004 | 679 | 2004 |
| Gastrointestinal dysfunction in Parkinson's disease RF Pfeiffer The Lancet Neurology 2 (2), 107-116, 2003 | 620 | 2003 |
| Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology LL Edwards, EMM Quigley, RF Pfeiffer Neurology 42 (4), 726-726, 1992 | 495 | 1992 |
| Gastrointestinal symptoms in Parkinson's disease LL Edwards, RF Pfeiffer, EMM Quigley, R Hofman, M Balluff Movement disorders: official journal of the Movement Disorder Society 6 (2 …, 1991 | 452 | 1991 |
| Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation C Singaram, EA Gaumnitz, C Torbey, W Ashraf, EMM Quigley, ... The Lancet 346 (8979), 861-864, 1995 | 431 | 1995 |
| A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease IH Richard, MP McDermott, R Kurlan, JM Lyness, PG Como, N Pearson, ... Neurology 78 (16), 1229-1236, 2012 | 382 | 2012 |
| Gastrointestinal dysfunction in Parkinson’s disease RF Pfeiffer Parkinsonism & related disorders 17 (1), 10-15, 2011 | 342 | 2011 |
| Autosomal dominant parkinsonism associated with variable synuclein and tau pathology ZK Wszolek, RF Pfeiffer, Y Tsuboi, RJ Uitti, RD McComb, AJ Stoessl, ... Neurology 62 (9), 1619-1622, 2004 | 327 | 2004 |
| Cognitive performance of GBA mutation carriers with early-onset PD: The CORE-PD study RN Alcalay, E Caccappolo, H Mejia-Santana, MX Tang, L Rosado, ... Neurology 78 (18), 1434-1440, 2012 | 296 | 2012 |
| A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014 | 293 | 2014 |
| Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset WC Nichols, N Pankratz, DK Marek, MW Pauciulo, VE Elsaesser, ... Neurology 72 (4), 310-316, 2009 | 267 | 2009 |
| Longitudinal outcome of Parkinson’s disease patients with psychosis SA Factor, PJ Feustel, JH Friedman, CL Comella, CG Goetz, R Kurlan, ... Neurology 60 (11), 1756-1761, 2003 | 264 | 2003 |
| Characterization of swallowing and defecation in Parkinson's disease. LL Edwards, EMM Quigley, RK Harned, R Hofman, RF Pfeiffer American Journal of Gastroenterology (Springer Nature) 89 (1), 1994 | 254 | 1994 |
| The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval A Zimprich, B Müller-Myhsok, M Farrer, P Leitner, M Sharma, M Hulihan, ... The American Journal of Human Genetics 74 (1), 11-19, 2004 | 253 | 2004 |
| Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey MF Siddiqui, S Rast, MJ Lynn, AP Auchus, RF Pfeiffer Parkinsonism & related disorders 8 (4), 277-284, 2002 | 247 | 2002 |
| Constipation in Parkinson's disease: objective assessment and response to psyllium W Ashraf, RF Pfeiffer, F Park, J Lof, EMM Quigley Movement Disorders 12 (6), 946-951, 1997 | 238 | 1997 |
| Expression and regulation of brain metallothionein M Ebadi, PL Iversen, R Hao, DR Cerutis, P Rojas, HK Happe, LC Murrin, ... Neurochemistry international 27 (1), 1-22, 1995 | 237 | 1995 |
